ERBB2 c.2533G>A ;(p.D845N)

Variant ID: 17-37881341-G-A

NM_004448.2(ERBB2):c.2533G>A;(p.D845N)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway.

Cell Metabolism
Kurmi, Kiran K; Hitosugi, Sadae S; Yu, Jia J; Boakye-Agyeman, Felix F; Wiese, Elizabeth K EK; Larson, Thomas R TR; Dai, Qing Q; Machida, Yuichi J YJ; Lou, Zhenkun Z; Wang, Liewei L; Boughey, Judy C JC; Kaufmann, Scott H SH; Goetz, Matthew P MP; Karnitz, Larry M LM; Hitosugi, Taro T
Publication Date: 2018-12-04

Variant appearance in text: HER2: D845N
PubMed Link: 30174304
Variant Present in the following documents:
  • Main text
View BVdb publication page



Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

Oncogene
Pradeep, C-R CR; Zeisel, A A; Köstler, W J WJ; Lauriola, M M; Jacob-Hirsch, J J; Haibe-Kains, B B; Amariglio, N N; Ben-Chetrit, N N; Emde, A A; Solomonov, I I; Neufeld, G G; Piccart, M M; Sagi, I I; Sotiriou, C C; Rechavi, G G; Domany, E E; Desmedt, C C; Yarden, Y Y
Publication Date: 2012-08-02

Variant appearance in text: HER2: D845N
PubMed Link: 22139081
Variant Present in the following documents:
  • Main text
View BVdb publication page